| Year |
Citation |
Score |
| 2019 |
Ortiz A, Gui J, Zahedi F, Yu P, Cho C, Bhattacharya S, Carbone CJ, Yu Q, Katlinski KV, Katlinskaya YV, Handa S, Haas V, Volk SW, Brice AK, Wals K, et al. An Interferon-Driven Oxysterol-Based Defense against Tumor-Derived Extracellular Vesicles. Cancer Cell. 35: 33-45.e6. PMID 30645975 DOI: 10.1016/J.Ccell.2018.12.001 |
0.591 |
|
| 2017 |
Katlinski KV, Gui J, Katlinskaya YV, Ortiz A, Chakraborty R, Bhattacharya S, Carbone CJ, Beiting DP, Girondo MA, Peck AR, Puré E, Chatterji P, Rustgi AK, Diehl JA, Koumenis C, et al. Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment. Cancer Cell. 31: 194-207. PMID 28196594 DOI: 10.1016/J.Ccell.2017.01.004 |
0.565 |
|
| 2015 |
Katlinskaya YV, Carbone CJ, Yu Q, Fuchs SY. Type 1 interferons contribute to the clearance of senescent cell. Cancer Biology & Therapy. 16: 1214-9. PMID 26046815 DOI: 10.1080/15384047.2015.1056419 |
0.456 |
|
| 2015 |
Yu Q, Katlinskaya YV, Carbone CJ, Zhao B, Katlinski KV, Zheng H, Guha M, Li N, Chen Q, Yang T, Lengner CJ, Greenberg RA, Johnson FB, Fuchs SY. DNA-damage-induced type I interferon promotes senescence and inhibits stem cell function. Cell Reports. 11: 785-97. PMID 25921537 DOI: 10.1016/J.Celrep.2015.03.069 |
0.385 |
|
| 2014 |
Bhattacharya S, Katlinski KV, Reichert M, Takano S, Brice A, Zhao B, Yu Q, Zheng H, Carbone CJ, Katlinskaya YV, Leu NA, McCorkell KA, Srinivasan S, Girondo M, Rui H, et al. Triggering ubiquitination of IFNAR1 protects tissues from inflammatory injury. Embo Molecular Medicine. 6: 384-97. PMID 24480543 DOI: 10.1002/Emmm.201303236 |
0.588 |
|
| 2014 |
Carbone CJ, Fuchs SY. Eliminative signaling by Janus kinases: role in the downregulation of associated receptors. Journal of Cellular Biochemistry. 115: 8-16. PMID 23959845 DOI: 10.1002/Jcb.24647 |
0.435 |
|
| 2013 |
Zheng H, Gupta V, Patterson-Fortin J, Bhattacharya S, Katlinski K, Wu J, Varghese B, Carbone CJ, Aressy B, Fuchs SY, Greenberg RA. A BRISC-SHMT complex deubiquitinates IFNAR1 and regulates interferon responses. Cell Reports. 5: 180-93. PMID 24075985 DOI: 10.1016/J.Celrep.2013.08.025 |
0.589 |
|
| 2013 |
Carbone CJ, Varghese B, Zheng H, Fuchs SY. 33 Cytokine. 63: 251. DOI: 10.1016/J.Cyto.2013.06.036 |
0.388 |
|
| 2012 |
Carbone CJ, Zheng H, Bhattacharya S, Lewis JR, Reiter AM, Henthorn P, Zhang ZY, Baker DP, Ukkiramapandian R, Bence KK, Fuchs SY. Protein tyrosine phosphatase 1B is a key regulator of IFNAR1 endocytosis and a target for antiviral therapies. Proceedings of the National Academy of Sciences of the United States of America. 109: 19226-31. PMID 23129613 DOI: 10.1073/Pnas.1211491109 |
0.639 |
|
| 2011 |
Zheng H, Qian J, Carbone CJ, Leu NA, Baker DP, Fuchs SY. Vascular endothelial growth factor-induced elimination of the type 1 interferon receptor is required for efficient angiogenesis. Blood. 118: 4003-6. PMID 21832278 DOI: 10.1182/Blood-2011-06-359745 |
0.42 |
|
| 2011 |
Qian J, Zheng H, Huangfu WC, Liu J, Carbone CJ, Leu NA, Baker DP, Fuchs SY. Pathogen recognition receptor signaling accelerates phosphorylation-dependent degradation of IFNAR1. Plos Pathogens. 7: e1002065. PMID 21695243 DOI: 10.1371/Journal.Ppat.1002065 |
0.501 |
|
| 2009 |
Liu J, Carvalho LP, Bhattacharya S, Carbone CJ, Kumar KG, Leu NA, Yau PM, Donald RG, Weiss MJ, Baker DP, McLaughlin KJ, Scott P, Fuchs SY. Mammalian casein kinase 1alpha and its leishmanial ortholog regulate stability of IFNAR1 and type I interferon signaling. Molecular and Cellular Biology. 29: 6401-12. PMID 19805514 DOI: 10.1128/Mcb.00478-09 |
0.609 |
|
| 2008 |
Varghese B, Barriere H, Carbone CJ, Banerjee A, Swaminathan G, Plotnikov A, Xu P, Peng J, Goffin V, Lukacs GL, Fuchs SY. Polyubiquitination of prolactin receptor stimulates its internalization, postinternalization sorting, and degradation via the lysosomal pathway. Molecular and Cellular Biology. 28: 5275-87. PMID 18573876 DOI: 10.1128/Mcb.00350-08 |
0.417 |
|
| 2008 |
Swaminathan G, Varghese B, Thangavel C, Carbone CJ, Plotnikov A, Kumar KG, Jablonski EM, Clevenger CV, Goffin V, Deng L, Frank SJ, Fuchs SY. Prolactin stimulates ubiquitination, initial internalization, and degradation of its receptor via catalytic activation of Janus kinase 2. The Journal of Endocrinology. 196: R1-7. PMID 18252943 DOI: 10.1677/Joe-07-0554 |
0.446 |
|
| 2007 |
Kumar KG, Barriere H, Carbone CJ, Liu J, Swaminathan G, Xu P, Li Y, Baker DP, Peng J, Lukacs GL, Fuchs SY. Site-specific ubiquitination exposes a linear motif to promote interferon-alpha receptor endocytosis. The Journal of Cell Biology. 179: 935-50. PMID 18056411 DOI: 10.1083/Jcb.200706034 |
0.452 |
|
| 2007 |
Carbone CJ, Graña X, Reddy EP, Haines DS. p21 loss cooperates with INK4 inactivation facilitating immortalization and Bcl-2-mediated anchorage-independent growth of oncogene-transduced primary mouse fibroblasts. Cancer Research. 67: 4130-7. PMID 17483323 DOI: 10.1158/0008-5472.Can-07-0499 |
0.574 |
|
| 2000 |
Autieri MV, Carbone C, Mu A. Expression of allograft inflammatory factor-1 is a marker of activated human vascular smooth muscle cells and arterial injury. Arteriosclerosis, Thrombosis, and Vascular Biology. 20: 1737-44. PMID 10894811 DOI: 10.1161/01.Atv.20.7.1737 |
0.316 |
|
| 1999 |
Autieri MV, Carbone CJ. 14-3-3Gamma interacts with and is phosphorylated by multiple protein kinase C isoforms in PDGF-stimulated human vascular smooth muscle cells. Dna and Cell Biology. 18: 555-64. PMID 10433554 DOI: 10.1089/104454999315105 |
0.426 |
|
| Show low-probability matches. |